History
Building validated technology toward platform commercialization
TheraNovis Co., Ltd. Established
MOU Signed with BioActs and Six Additional Organizations
Established Corporate R&D Centers (Hanam / Yangsan)
Executing the Regional Specialized Industry Development Program (MSS)
Selected for PNU Yangsan Bio Core Facility Program (KRW 600M / 3 years)
Selected for the KIBO Tech-Bridge Program
Selected for the Asan Medical Center Incentive Program
Secured KRW 300M in TIPS funding
Secured KRW 336M in strategic (SI) investment
Selected for MSS Deep-Tech TIPS Program (KRW 1.5B / 3 years)
Selected for Seoul-type TIPS Program (KRW 400M / 2 years)
Selected for Medical Device Industry Transition Infrastructure Program
Launch of Phenoview (now AstraTSA)
MOU signed with AtheonBio
MOU signed with Intec Scientific
Selected for MOTIE Materials & Components Technology Development Program (KRW 10B / 5 years)
Initiated establishment of Boston, USA liaison office
Secured KRW 1B in strategic (SI) investment from IntekPlus
Launch of Skin GeneCurator skin condition assessment service
Launch of semi-automated staining system
Secured KRW 220M in funding from a private investment fund
Tap an item to highlight it.